Growth Metrics

Ceribell (CBLL) Net Cash Flow Growth (1y) (2024 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Ceribell 666.26 Mn 525.07 Mn 23.12 Mn 111.65%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 111.65%
Dec 31, 2025 -90.72%
Sep 30, 2025 -60.07%
Jun 30, 2025 -1,291.92%
Mar 31, 2025 -1,946.41%
Dec 31, 2024 1,765.99%